TELA Bio Inc. (TELA) |
|
12.01 0.18 (1.52%)
|
01-21 18:34 |
|
Open: |
12.04 |
Pre. Close: |
11.83 |
|
High:
|
12.24 |
Low:
|
11.975 |
|
Volume:
|
7,782 |
Market Cap:
|
174M |
|
|
|
|
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
12.264 - 12.333 |
12.333 - 12.409 |
|
Low:
|
11.784 - 11.862 |
11.862 - 11.946 |
|
Close:
|
11.865 - 11.999 |
11.999 - 12.144 |
|
Technical analysis |
as of: 2022-01-21 4:30:56 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 15.07 One year: 16.00 |
| Support: |
Support1: 11.61 Support2: 9.66 |
| Resistance: |
Resistance1: 12.90 Resistance2: 13.70 |
| Pivot: |
12.50 |
| Moving Average: |
MA(5): 12.05 MA(20): 12.48
MA(100): 12.68 MA(250): 13.70 |
| MACD: |
MACD(12,26): -0.14 Signal(9): -0.08 |
| Stochastic oscillator: |
%K(14,3): 19.28  %D(3): 14.25 |
| RSI: |
RSI(14): 43.50 |
| 52-week: |
High: 18.00 Low: 11.03 Change(%): -12.9 |
| Average Vol(K): |
3-Month: 18 10-Days: 62 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.TELA has closed above bottom band by 23.4%. Bollinger Bands are 56% wider than normal. The large width of the bands suggest high volatility as compared to TELA Bio Inc.'s normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 19 Jan 2022
Form SC 13D/A TELA Bio, Inc. Filed by: EW HEALTHCARE PARTNERS FUND 2, LP - StreetInsider.com
Fri, 14 Jan 2022
TELA Bio - Follow Up With Management - Seeking Alpha
Mon, 10 Jan 2022
TELA Bio, Inc. to Post FY2021 Earnings of ($2.25) Per Share, Jefferies Financial Group Forecasts (NASDAQ:TELA) - MarketBeat
Fri, 31 Dec 2021
Aroa Biosurgery: Advancing Low Cost Soft Tissue Regeneration - Seeking Alpha
Wed, 10 Nov 2021
TELA Bio Reports Strong Third Quarter 2021 Revenues Reflecting Continued Growth Driven by Increased Demand - GlobeNewswire
Mon, 25 Oct 2021
TELA Bio Plugging Away - Seeking Alpha
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
15 |
| Shares Float (M) |
5 |
|
% Held by Insiders
|
7.61 |
|
% Held by Institutions
|
88.19 |
|
Shares Short (K)
|
63 |
|
Shares Short P. Month (K)
|
73 |
Stock Financials |
|
EPS
|
-2.240 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
1.910 |
|
Profit Margin
|
-121.27 |
|
Operating Margin
|
-106.68 |
|
Return on Assets (ttm)
|
-22.1 |
|
Return on Equity (ttm)
|
-77.2 |
|
Qtrly Rev. Growth
|
44.1 |
|
Gross Profit (p.s.)
|
0.796 |
|
Sales Per Share
|
1.846 |
|
EBITDA (p.s.)
|
-1.932 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-28 |
|
Levered Free Cash Flow (M)
|
-17 |
Stock Valuations |
|
PE Ratio
|
-5.36 |
|
PEG Ratio
|
|
|
Price to Book value
|
6.29 |
|
Price to Sales
|
6.51 |
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
